
Establishment Labs Holdings ESTA
$ 60.1
-0.39%
Annual report 2025
added 02-27-2026
Establishment Labs Holdings Accounts Payables 2011-2026 | ESTA
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Establishment Labs Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43.1 M | 44.8 M | 41.6 M | 20 M | 14.5 M | 9.72 M | 10.4 M | 6.24 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 44.8 M | 6.24 M | 23.8 M |
Quarterly Accounts Payables Establishment Labs Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39.7 M | 55.8 M | 45.2 M | 44.8 M | 34.4 M | 28.4 M | 31.1 M | 41.6 M | 28.9 M | 24.4 M | 20.3 M | 20 M | 14.9 M | 16 M | 16.7 M | 14.5 M | 10.3 M | 10 M | 8.99 M | 9.72 M | 9.72 M | 9.72 M | 9.72 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 6.24 M | 6.24 M | 6.24 M | 6.24 M | 9.13 M | 9.13 M | 9.13 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 55.8 M | 6.24 M | 18.8 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
2.76 M | - | -26.83 % | $ 2.62 M | ||
|
FONAR Corporation
FONR
|
1.55 M | $ 18.58 | -0.11 % | $ 122 M | ||
|
AdaptHealth Corp.
AHCO
|
352 M | $ 12.0 | -0.58 % | $ 1.62 B | ||
|
Allied Healthcare Products
AHPI
|
1.21 M | - | 3.58 % | $ 2.21 M | ||
|
Globus Medical
GMED
|
98.9 M | $ 90.43 | 2.07 % | $ 12.2 B | ||
|
ClearPoint Neuro
CLPT
|
1.26 M | $ 9.11 | -2.88 % | $ 258 M | ||
|
Bruker Corporation
BRKR
|
234 M | $ 36.38 | -0.98 % | $ 5.42 K | ||
|
Helius Medical Technologies
HSDT
|
531 K | $ 1.8 | -5.53 % | $ 1.09 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
82.5 M | $ 9.25 | -0.64 % | $ 712 M | ||
|
Inspire Medical Systems
INSP
|
36.6 M | $ 54.48 | 0.63 % | $ 1.6 B | ||
|
IRIDEX Corporation
IRIX
|
5.38 M | $ 1.03 | 3.35 % | $ 17.4 M | ||
|
Integer Holdings Corporation
ITGR
|
113 M | $ 85.52 | -0.13 % | $ 2.97 B | ||
|
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | ||
|
LENSAR
LNSR
|
19 M | $ 5.77 | -2.04 % | $ 69 M | ||
|
OrthoPediatrics Corp.
KIDS
|
18.8 M | $ 15.82 | -0.75 % | $ 371 M | ||
|
Medtronic PLC
MDT
|
2.45 B | $ 86.33 | 0.06 % | $ 111 B | ||
|
EDAP TMS S.A.
EDAP
|
5.71 M | $ 3.42 | -1.16 % | $ 128 M | ||
|
Myomo
MYO
|
1.51 M | $ 0.67 | -4.85 % | $ 28 M | ||
|
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | ||
|
Align Technology
ALGN
|
109 M | $ 168.21 | -2.13 % | $ 12.6 B | ||
|
Orthofix Medical
OFIX
|
58.4 M | $ 11.81 | 0.34 % | $ 468 M | ||
|
AxoGen
AXGN
|
2.89 M | $ 31.01 | -4.99 % | $ 1.43 B | ||
|
Axonics Modulation Technologies
AXNX
|
9.07 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
4.79 M | - | 1.37 % | $ 20.5 M | ||
|
Insulet Corporation
PODD
|
75 M | $ 204.23 | 0.36 % | $ 14.4 B | ||
|
Sintx Technologies
SINT
|
382 K | $ 2.76 | 9.09 % | $ 7.65 M | ||
|
Butterfly Network
BFLY
|
4.25 M | $ 4.02 | -2.66 % | $ 851 M | ||
|
Stryker Corporation
SYK
|
1.8 B | $ 331.18 | -0.34 % | $ 127 B | ||
|
Tactile Systems Technology
TCMD
|
4.97 M | $ 24.16 | -1.67 % | $ 553 M | ||
|
Cytosorbents Corporation
CTSO
|
2.87 M | $ 0.61 | 3.37 % | $ 38 M | ||
|
TELA Bio
TELA
|
2.31 M | $ 0.7 | 11.11 % | $ 32.9 M | ||
|
TransMedics Group
TMDX
|
10.4 M | $ 107.91 | 2.97 % | $ 3.67 B | ||
|
Tandem Diabetes Care
TNDM
|
47.1 M | $ 18.66 | -2.66 % | $ 1.27 B | ||
|
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
2.66 M | $ 9.68 | -0.21 % | $ 347 M | ||
|
Boston Scientific Corporation
BSX
|
1.14 B | $ 61.33 | -2.01 % | $ 90.8 B | ||
|
Alphatec Holdings
ATEC
|
40.9 M | $ 11.09 | 1.05 % | $ 1.66 B |